178 related articles for article (PubMed ID: 22205060)
1. Pathophysiology of the metabolic syndrome: implications for the cardiometabolic risks associated with type 2 diabetes.
Leroith D
Am J Med Sci; 2012 Jan; 343(1):13-6. PubMed ID: 22205060
[TBL] [Abstract][Full Text] [Related]
2. New insights into understanding cardiometabolic risk. Introduction.
Fonarow GC; Watson KE
Rev Cardiovasc Med; 2007; 8 Suppl 4():S1-2. PubMed ID: 17934389
[No Abstract] [Full Text] [Related]
3. Targeting abdominal obesity and the metabolic syndrome to manage cardiovascular disease risk.
Després JP
Heart; 2009 Jul; 95(13):1118-24. PubMed ID: 19525261
[No Abstract] [Full Text] [Related]
4. Clinical implications of the metabolic syndrome.
Ceska R
Diab Vasc Dis Res; 2007 Sep; 4 Suppl 3():S2-4. PubMed ID: 17935057
[TBL] [Abstract][Full Text] [Related]
5. The progression of cardiovascular risk to cardiovascular disease.
Rosin BL
Rev Cardiovasc Med; 2007; 8 Suppl 4():S3-8. PubMed ID: 17934392
[TBL] [Abstract][Full Text] [Related]
6. Ethnicity and genetics are more important than diabetes mellitus and hypertension in producing cardiovascular events in patients with the metabolic syndrome: emphasis in the Puerto Rico population.
Altieri PI; Marcial JM; Banchs H; Escobales N; Crespo M
Bol Asoc Med P R; 2013; 105(3):56-63. PubMed ID: 24282924
[TBL] [Abstract][Full Text] [Related]
7. Identification and management of cardiometabolic risk in Canada: a position paper by the cardiometabolic risk working group (executive summary).
; Leiter LA; Fitchett DH; Gilbert RE; Gupta M; Mancini GB; McFarlane PA; Ross R; Teoh H; Verma S; Anand S; Camelon K; Chow CM; Cox JL; Després JP; Genest J; Harris SB; Lau DC; Lewanczuk R; Liu PP; Lonn EM; McPherson R; Poirier P; Qaadri S; Rabasa-Lhoret R; Rabkin SW; Sharma AM; Steele AW; Stone JA; Tardif JC; Tobe S; Ur E
Can J Cardiol; 2011; 27(2):124-31. PubMed ID: 21459258
[TBL] [Abstract][Full Text] [Related]
8. Mixed dyslipidemia, metabolic syndrome, diabetes mellitus, and cardiovascular disease: clinical implications.
Cannon CP
Am J Cardiol; 2008 Dec; 102(12A):5L-9L. PubMed ID: 19084083
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular risk in the spectrum of type 2 diabetes mellitus.
Ahmed I; Goldstein BJ
Mt Sinai J Med; 2006 Sep; 73(5):759-68. PubMed ID: 17008936
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular outcomes for obesity and metabolic syndrome.
Vega GL
Obes Res; 2002 Nov; 10 Suppl 1():27S-32S. PubMed ID: 12446855
[No Abstract] [Full Text] [Related]
11. Metabolic syndrome, diabetes and cardiovascular events: current controversies and recommendations.
Zarich SW
Minerva Cardioangiol; 2006 Apr; 54(2):195-214. PubMed ID: 16778752
[TBL] [Abstract][Full Text] [Related]
12. Unmet needs in controlling metabolic disease.
Haffner SM
Rev Cardiovasc Med; 2007; 8 Suppl 4():S17-24. PubMed ID: 17934390
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome, cardiovascular disease and type-2 diabetes.
Bano KA; Batool A
J Pak Med Assoc; 2007 Oct; 57(10):511-5. PubMed ID: 17990428
[TBL] [Abstract][Full Text] [Related]
14. Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group.
; Leiter LA; Fitchett DH; Gilbert RE; Gupta M; Mancini GB; McFarlane PA; Ross R; Teoh H; Verma S; Anand S; Camelon K; Chow CM; Cox JL; Després JP; Genest J; Harris SB; Lau DC; Lewanczuk R; Liu PP; Lonn EM; McPherson R; Poirier P; Qaadri S; Rabasa-Lhoret R; Rabkin SW; Sharma AM; Steele AW; Stone JA; Tardif JC; Tobe S; Ur E
Can J Cardiol; 2011; 27(2):e1-e33. PubMed ID: 21459257
[TBL] [Abstract][Full Text] [Related]
15. The metabolic syndrome and type 2 diabetes.
Poole R; Byrne CD
Minerva Endocrinol; 2005 Sep; 30(3):139-59. PubMed ID: 16208305
[TBL] [Abstract][Full Text] [Related]
16. Is the concept of 'cardiometabolic risk' more useful than 'metabolic syndrome'?
Koshiyama H; Taniguchi A; Inagaki N; Seino Y
Diabet Med; 2007 May; 24(5):571. PubMed ID: 17470194
[No Abstract] [Full Text] [Related]
17. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds.
Grundy SM
J Am Coll Cardiol; 2006 Mar; 47(6):1093-100. PubMed ID: 16545636
[TBL] [Abstract][Full Text] [Related]
18. The concept of cardiometabolic risk: Bridging the fields of diabetology and cardiology.
Després JP; Cartier A; Côté M; Arsenault BJ
Ann Med; 2008; 40(7):514-23. PubMed ID: 18608131
[TBL] [Abstract][Full Text] [Related]
19. The metabolic syndrome, type 2 diabetes, and cardiovascular disease: understanding the role of insulin resistance.
Kendall DM; Harmel AP
Am J Manag Care; 2002 Dec; 8(20 Suppl):S635-53; quiz S654-7. PubMed ID: 12510788
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome: what are the risks for humans?
Gupta A; Gupta V
Biosci Trends; 2010 Oct; 4(5):204-12. PubMed ID: 21068471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
